Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response

OBJECTIVE: The study objective was to assess the safety and efficacy of a preemptive direct-acting antiviral therapy in lung transplants from hepatitis C virus donors to uninfected recipients. METHODS: This study is a prospective, open-label, nonrandomized, pilot trial. Recipients of hepatitis C vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Villavicencio, Mauricio A., Li, Selena S., Leifer, Ann Marie, Gustafson, Jenna L., Osho, Asishana, Wolfe, Stanley, Raz, Yuval, Griffith, Jason, Neuringer, Isabel, Bethea, Emily, Gift, Thais, Waldman, Georgina, Astor, Todd, Langer, Nathaniel B., Chung, Raymond T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Thoracic: Lung Transplantation: Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328796/
https://www.ncbi.nlm.nih.gov/pubmed/37425441
http://dx.doi.org/10.1016/j.xjon.2023.02.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328796/
https://www.ncbi.nlm.nih.gov/pubmed/37425441
http://dx.doi.org/10.1016/j.xjon.2023.02.014

Ejemplares similares